Agilent Technologies supports research at the Broad developing proteomics technology to detect disease

摘要

Agilent Technologies and the Agilent Technologies Foundation recently announced that Steven Carr, Ph.D, who directs the Proteomics Platform at the Broad Institute of MIT and Harvard, has been selected for an Agilent Thought Leader Award supporting his work developing new technology for analysing proteins and peptides. Carr's goal is to produce better techniques for diagnosing illnesses such as cardiovascular disease, breast cancer and ovarian cancer.